Respiratory Motion

Respiratory Motion

Providing early warning of respiratory collapse across diverse patient populations and medical environments.

Founded 2010 11-50 employees Series D Total: $33.50M Biotechnology, Health Care +1

Respiratory Motion, a commercial-stage medical device company founded in 2010, is dedicated to providing early warnings of respiratory collapse across diverse patient populations and medical environments. The company's slogan "Providing early warning of respiratory collapse across diverse patient populations and medical environments" reflects its core mission to evaluate respiratory function and offer crucial early warnings. Specializing in the Biotechnology, Health Care, and Medical Devices industries, Respiratory Motion focuses on medical devices, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company's latest milestone includes securing a substantial $17.70M Series D investment on 01 May 2019, signaling confidence and support from the investment community. While the specific details of the investors were not disclosed, this significant investment represents a vote of confidence in Respiratory Motion's innovative approach and potentially game-changing solutions in the critical area of respiratory care.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$17.70M	-		01 May 2019
Venture Round	Undisclosed	1	Tech Coast Angels	01 Oct 2018
Venture Round	Undisclosed	10	eCoast Angels, Golden Seeds +8	13 Jul 2017
Venture Round	Undisclosed	1	Walnut Venture Associates	09 Dec 2015
Series C	$6.50M	1	Cherrystone Angel Group	01 Mar 2015
Venture Round	Undisclosed	1	Tech Coast Angels	01 Oct 2014
Series B	$7.80M	1	Easton Capital	26 Feb 2014
Venture Round	Undisclosed	3	Beta Fund, Maine Angels +1	01 Dec 2013
Convertible Note	Undisclosed	2	Cherrystone Angel Group, Beta Fund	01 Jul 2013
Convertible Note	Undisclosed	4	Cherrystone Angel Group, Beta Fund +2	01 Mar 2013

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$17.70M

01 May 2019

Venture Round

Undisclosed

Tech Coast Angels

01 Oct 2018

Venture Round

Undisclosed

eCoast Angels, Golden Seeds +8

13 Jul 2017

Venture Round

Undisclosed

Walnut Venture Associates

09 Dec 2015

Series C

$6.50M

Cherrystone Angel Group

01 Mar 2015

Venture Round

Undisclosed

Tech Coast Angels

01 Oct 2014

Series B

$7.80M

Easton Capital

26 Feb 2014

Venture Round

Undisclosed

Beta Fund, Maine Angels +1

01 Dec 2013

Convertible Note

Undisclosed

Cherrystone Angel Group, Beta Fund

01 Jul 2013

Convertible Note

Undisclosed

Cherrystone Angel Group, Beta Fund +2

01 Mar 2013

FAQ About Respiratory Motion

Providing early warning of respiratory collapse across diverse patient populations and medical environments.

Respiratory Motion was founded in 2010.

Respiratory Motion operates in Biotechnology, Health Care and Medical Devices. Its work centres on respiratory monitoring, clinical testing, patient populations and respiratory function.

Respiratory Motion has approximately 11-50 employees.

Respiratory Motion has completed 15 funding rounds, raising a total of $33.50M. The latest funding stage is Series D.

Top alternatives and competitors to Respiratory Motion include KerNel Biomedical, Apple Homecare Medical Supply, Nihon Kohden Europe, ArtiQ, Diopsys. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Respiratory Motion and KerNel Biomedical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Respiratory Motion

Funding Rounds & Investors (15)

Respiratory Motion Alternatives & Competitors

FAQ About Respiratory Motion